Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:38:00 13/02/2026 GMT			5-day change	1st Jan Change
45.98 ^EUR	+0.65%		+0.40%	+24.25%

02-13	China Promises German Companies Fair Competitive Conditions	RE
02-13	China holds roundtable meeting with German companies	RE

Bayer Hit with $100 Million Verdict by US Jury Over US School Contamination

Published on 01/15/2025 at 05:14 am GMT - Modified on 01/15/2025 at 05:15 am GMT

MT Newswires

Latest news about Bayer AG

02-13	China Promises German Companies Fair Competitive Conditions	RE
02-13	China holds roundtable meeting with German companies	RE
02-11	Pharma companies left out of Trump's drug-pricing deals look for way in	RE
02-11	Major U-turns on corporate splits in recent years	RE
02-11	Pharma companies left out of Trump's drug-pricing deals look for way in	RE
02-11	Major U-turns on corporate splits over the years	RE
02-11	Major U-turns on corporate splits in recent years	RE
02-11	German drugmakers lobby says US price rules will challenge domestic market	RE
02-11	German drugmakers lobby says US price rules will challenge domestic market	RE
02-09	BAYER AG : Goldman Sachs reiterates its Buy rating	ZD
02-07	Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides	DJ
02-06	BAYER AG : Gets a Buy rating from Barclays	ZD
02-06	Bayer Hesitates to Raise Sales Forecast Despite Asundexian Breakthrough	RE
02-06	Bayer Aktiengesellschaft - Special Call
02-06	Bayer confident in asundexian but too early to comment on specific peak sales numbers	RE

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.6%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Employees

88,502

Sector

Pharmaceuticals

Calendar

04-23 - Annual General Meeting

More about the company